CT Colonography during COVID-19

ARGANZ Statement

Background

Guidance has been sought on a unified position for the use of CT Colonography (CTC) in Australia and New Zealand during the COVID-19 pandemic.  On review of the limited evidence, a consensus has been reached among radiologists from the two countries.

It should be noted that the ANZ clinical scenario is currently different from those in other countries.  Also that the quoted evidence for risks associated with optical colonoscopy (OC) cannot be directly applied to CTC.

ARGANZ Online Learning

Missing The ARGANZ Meeting This Weekend?

Have a desire for some abdomino-pelvic learning?

The ARGANZ executive has some suggestions for you.

Preferably log in to the ARGANZ website first at www.arganz.org so the ARGANZ website links will take you directly to the relevant pages.

ARGANZ at SAR

There were 20 ANZ delegates at the recent SAR (Society of Abdominal Radiology) meeting in Hawaii. Dr Kirsten Gormly (SA) was an invited plenary speaker on rectal MRI and gave a workshop on peritoneal disease, and Dr Rajeev Jyoti (ACT) presented at a workshop on Prostate MR.

Kirsten took the opportunity to discuss future ARGANZ-SAR relations with the current and incoming SAR presidents, Jonathan Kruskal and Desiree Morgan and generally raise the profile of abdominal radiology in Australia & New Zealand.

COVID-19. 2020 Meeting Cancelled

ARGANZ 2020 CANCELLED

It is with regret that the ARGANZ executive has decided to cancel the 2020 ARGANZ meeting due to occur from the 27-29 March 2020 at the Brisbane Convention and Exhibition Centre, Brisbane, Australia. 

Following the outbreak of coronavirus (COVID-19), travel restrictions are in place in a number of countries, and by employers both in Australia and New Zealand, affecting ARGANZ delegates and speakers.  We have been advised today that both of our International Speakers, Prof Valerie Vilgrain and Prof Giuseppe Brancatelli are also now under travel restrictions and are unable to attend.

ESGAR 2019

A number of Australians and New Zealanders attended this years ESGAR meeting in Rome.  Current Chair Kirsten Gormly and executive member Jessica Yang hosted an ARGANZ at ESGAR dinner and spoke at the meeting.  It was wonderful to see so many 'locals' and gather ideas on ways ARGANZ may be able to connect with its members. Congratulations to Dr Edwin Ho from Sydney for his poster winning an ESGAR award. 2018 Mendelson Research Prize winner Dr Danielle Richmond from Melbourne enjoyed her free trip (click on the images to see full-sized images and slideshow)

New liver Medicare rebates in Australia

ARGANZ, acting on behalf of RANZCR, has been the lead applicant campaigning for a liver MRI rebate. After an extensive process this has now been approved for two patient populations. The first is patients with colorectal carcinoma and suspected liver metastases for the purpose of characterisation or interventional planning. The second patient population is patients with chronic liver disease (Childs-Pugh A&B) with known or suspected hepatocellular carcinoma and a liver lesion over 10mm. An additional item number has been created to co-claim hepatobiliary contrast agents, recognising that these are considerably more expensive for providers. The item numbers are likely to become active in May 2019.